First pediatric case with primary familial brain calcification due to a novel variant on the MYORG gene and review of the literature.

Childhood Fahr disease Myogenesis-regulating glycosidase (MYORG) gene Primary familial brain calcification

Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 25 11 2020
revised: 09 04 2021
accepted: 13 04 2021
pubmed: 8 5 2021
medline: 14 1 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

Variants in the myogenesis-regulating glycosidase (MYORG) gene which is known as the first autosomal recessive gene that has been associated with primary familial brain calcification (AR-PFBC). Although adult patients have been reported, no pediatric case has been reported until now. Herein, we review the clinical and radiological features of all AR- PFBC patients with biallelic variants in the MYORG gene who were reported until now, and we report the youngest patient who has a novel homozygous variant. Since the first identification of the MYORG gene in 2018, 74cases of MYORG variants related to AR-PFBC were evaluated. The ages of symptom onset of the patients ranged between 7.5 and 87 years. The most frequent clinical courses were speech impairment, movement disorder and cerebellar signs. All patients showed basal ganglia calcification usually bilaterally with different severities. Conclusion; herein, we reported the first pediatric patient in the literature who had a novel homozygous variant in the MYORG gene with mild clinic findings.

Identifiants

pubmed: 33958240
pii: S0387-7604(21)00067-X
doi: 10.1016/j.braindev.2021.04.002
pii:
doi:

Substances chimiques

Glycoside Hydrolases EC 3.2.1.-
MYORG protein, human EC 3.2.1.-

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

789-797

Informations de copyright

Copyright © 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Leman Tekin Orgun (L)

Baskent University, Faculty of Medicine, Department of Pediatric Neurology, Adana Dr. Noyan Teaching and Medical Research Center, Adana, Turkey. Electronic address: ltekinorgun@ankara.baskent.edu.tr.

Şeyda Besen (Ş)

Baskent University, Faculty of Medicine, Department of Pediatric Neurology, Adana Dr. Noyan Teaching and Medical Research Center, Adana, Turkey.

Özlem Sangün (Ö)

Baskent University, Faculty of Medicine, Department of Pediatric Endocrinology, Adana Dr. Noyan Teaching and Medical Research Center, Adana, Turkey.

Atıl Bisgin (A)

Cukurova University AGENTEM (Adana Genetic Disease Diagnosis and Treatment Center) & Medical Genetics Department of Medical Faculty, Adana, Turkey. Electronic address: abisgin@cu.edu.tr.

Özlem Alkan (Ö)

Baskent University, Faculty of Medicine, Department of Radiodiagnosis, Adana Dr. Noyan Teaching and Medical Research Center, Adana, Turkey.

İlknur Erol (İ)

Baskent University, Faculty of Medicine, Department of Pediatric Neurology, Adana Dr. Noyan Teaching and Medical Research Center, Adana, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH